CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,062,659 | -19.3% | 508,100 | -0.1% | 0.06% | -14.1% |
Q2 2023 | $28,561,674 | +24.1% | 508,758 | 0.0% | 0.07% | +22.4% |
Q1 2023 | $23,011,124 | +11.3% | 508,758 | 0.0% | 0.06% | +1.8% |
Q4 2022 | $20,681,013 | -37.8% | 508,758 | 0.0% | 0.06% | -41.2% |
Q3 2022 | $33,247,000 | -5.8% | 508,758 | -12.4% | 0.10% | +1.0% |
Q2 2022 | $35,302,000 | -3.2% | 580,918 | 0.0% | 0.10% | +17.1% |
Q1 2022 | $36,464,000 | -17.2% | 580,918 | 0.0% | 0.08% | 0.0% |
Q4 2021 | $44,022,000 | -32.3% | 580,918 | 0.0% | 0.08% | -33.9% |
Q3 2021 | $65,022,000 | -30.9% | 580,918 | 0.0% | 0.12% | -29.1% |
Q2 2021 | $94,045,000 | +31.5% | 580,918 | -1.0% | 0.18% | +25.9% |
Q1 2021 | $71,504,000 | -26.7% | 586,818 | -7.9% | 0.14% | -30.2% |
Q4 2020 | $97,546,000 | +51.8% | 637,100 | -17.1% | 0.20% | +31.8% |
Q3 2020 | $64,256,000 | -18.9% | 768,250 | -28.7% | 0.15% | -23.0% |
Q2 2020 | $79,222,000 | +73.3% | 1,078,000 | 0.0% | 0.20% | +46.3% |
Q1 2020 | $45,718,000 | -40.5% | 1,078,000 | -14.6% | 0.13% | -21.6% |
Q4 2019 | $76,844,000 | +117.6% | 1,261,700 | +46.4% | 0.17% | +96.6% |
Q3 2019 | $35,320,000 | -9.8% | 861,663 | +3.6% | 0.09% | -8.4% |
Q2 2019 | $39,171,000 | +43.5% | 831,663 | +8.8% | 0.10% | +39.7% |
Q1 2019 | $27,299,000 | +25.0% | 764,263 | 0.0% | 0.07% | +13.3% |
Q4 2018 | $21,835,000 | -35.6% | 764,263 | 0.0% | 0.06% | -24.1% |
Q3 2018 | $33,895,000 | -8.6% | 764,263 | +21.0% | 0.08% | -27.5% |
Q2 2018 | $37,101,000 | – | 631,400 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |